IP Library Granted Patent US 8,623,610
Granted Patent B2
US 8,623,610 · App. 11/751,880 · Granted Jan 7, 2014

Chondroitin sulfate binding proteins and modulators thereof

Inventors: Cristal I. Gama (Los Angeles, CA); Sarah E. Tully (Olmstead, OH); Linda C. Hsieh-Wilson (San Marino, CA)
Assignee: California Institute of Technology
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,623,610
App. No.
11/751,880
Granted
Jan 7, 2014
Kind
B2
Abstract

Chondroitin sulfate polysaccharides with defined sulfation patterns can be synthesized. These chondroitin polysaccharides can be used to identify chondroitin sulfate binding proteins. Further, compounds that modulate the activity of chondroitin sulfate binding proteins can be identified. For example, TNF-α was found to bind specifically to CS-E and CS-E can be used to modulate the interaction of TNF-α with the TNF receptor.

Claims (16)

1. A composition comprising homogeneous populations of chondroitin sulfate carbohydrates, wherein each homogeneous population of chondroitin sulfate carbohydrates is immobilized on an addressable location on a substrate, wherein each of said addressable locations is homogeneous for a particular chondroitin sulfate carbohydrate, wherein each of said addressable locations is separate from another addressable location, wherein said substrate comprises two or more addressable locations comprising chondroitin sulfate carbohydrates displaying different sulfation sequences, and wherein said chondroitin sulfate carbohydrates are selected from the group consisting of chondroitin sulfate A, chondroitin sulfate C, and chondroitin sulfate E.

2. The composition of claim 1 , wherein the substrate comprises a bead or a particle.

3. The composition of claim 2 , wherein the bead or particle comprises a paramagnetic bead or particle.

4. The composition of claim 2 , wherein the bead or particle comprises one or more of agarose, polystyrene, cellulose, cellulose acetate, carboxymethylcellulose, alginate, polyacrylamide, polyacrylate, polymethacrylic acid, polyvinylchloride, polytetrafluoroethylene, polyvinylacetate, silica, or glass.

5. The composition of claim 1 , wherein the substrate comprises a glass substrate.

6. A composition comprising one or more homogeneous populations of chondroitin sulfate carbohydrates, wherein each of the one or more homogeneous populations of chondroitin sulfate carbohydrates is immobilized on an addressable location on a substrate, wherein each of said addressable locations is homogeneous for a particular chondroitin sulfate carbohydrate, wherein said each of said addressable locations is separate from another addressable location of chondroitin sulfate carbohydrate on the substrate, and wherein the substrate comprises a poly-Lysine coated substrate.

7. The composition of claim 6 , wherein the poly-Lysine comprises poly-D-Lysine.

8. The composition of claim 6 , wherein the poly-Lysine comprises poly-L-Lysine.

9. The composition of claim 6 , wherein the CS molecules are non-covalently attached to a glass substrate.

10. The composition of claim 6 , wherein the CS molecules are covalently attached to the glass substrate.

11. The composition of claim 1 , wherein the CS is attached to the solid support in the form of an array.

12. The composition of claim 11 , wherein the chondroitin sulfate is selected from the group consisting of: a chondroitin sulfate A (CS-A) tetrasaccharide, a chondroitin sulfate C(CS-C) tetrasaccharide, a chondroitin sulfate E (CS-E) tetrasaccharide, a CS-A disaccharide, a CS-C disaccharide and a CS-E disaccharide.

13. The composition of claim 1 , wherein each population of chondroitin sulfate comprises a chondroitin sulfate selected from the group consisting of: a chondroitin sulfate A (CS-A) tetrasaccharide, a chondroitin sulfate C(CS-C) tetrasaccharide, a chondroitin sulfate E (CS-E) tetrasaccharide, a CS-A disaccharide, a CS-C disaccharide and a CS-E disaccharide.

14. The composition of claim 1 , wherein the CS polysaccharides are tetrasaccharides.

15. The composition of claim 1 , wherein the CS polysaccharides are disaccharides.

16. The composition of claim 1 , wherein said substrate is a poly-L-lysine coated glass substrate.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jul 30, 2008
From: CALIFORNIA INSTITUTE OF TECHNOLOGY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021318/0940 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2007
From: GAMA, CRISTAL I.; TULLY, SARAH E.; HSIEH-WILSON, LINDA C.
To: CALIFORNIA INSTITUTE OF TECHNOLOGY
Reel/Frame 019696/0935 →
Continuity (2)
Provisional Application 60802414 · May 22, 2006
Related Publication 20070275412A1 · Nov 29, 2007